The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?

@inproceedings{Jeon2015TheRO,
  title={The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?},
  author={Won Je Jeon and Brian Dean and Elizabeth Scarr and Andrew S. Gibbons},
  booktitle={Current neuropharmacology},
  year={2015}
}
The central cholinergic system has been implicated in the pathophysiology of mood disorders. An imbalance in central cholinergic neurotransmitter activity has been proposed to contribute to the manic and depressive episodes typical of these disorders. Neuropharmacological studies into the effects of cholinergic agonists and antagonists on mood state have provided considerable support for this hypothesis. Furthermore, recent clinical studies have shown that the pan-CHRM antagonist, scopolamine… CONTINUE READING
3
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-8 OF 8 CITATIONS

Na+, K+-ATPase Signaling and Bipolar Disorder

  • International journal of molecular sciences
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 117 REFERENCES

No evidence for association between 19 cholinergic genes and bipolar disorder.

  • American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2007
VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL